SynthesisPloS one2025
The association between serum lipid levels and colorectal cancer risk: A dose-response meta-analysis of 23 studies.
Synthesis in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- YAP1‑mediated cytoplasmic‑nuclear translocation of SREBP2 promotes colorectal cancer via regulation of cholesterol metabolism.International journal of oncology · 2026Article
- Metabolic and Laboratory Biomarkers in Early-Onset Versus Late-Onset Colorectal Cancer: A Case-Control Study.Cancers · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundColorectal cancer (CRC) ranks as the third most prevalent cancer globally and the second leading cause of cancer-related mortality. Based on recent studies, lipid levels may have a relationship with the risk of CRC. This meta-analysis aims to better understand the association between various serum lipids and CRC risk.
methodsA comprehensive search was conducted in Web of Science, PubMed, and Scopus. This meta-analysis, including only prospective cohort studies, performed random-effects meta-analyses using the Restricted Maximum Likelihood (REML) model to assess the association between the highest versus lowest categories of serum triglycerides (TG), total cholesterol (TC), high-density lipoprotein (HDL), and low-density lipoproteins (LDL) with the risk of CRC, primarily using hazard ratios (HR) as the effect size. Subgroup analyses (e.g., by tumor site, region, and risk of bias) and meta-regression analyses (e.g., for mean age, mean BMI, sex distribution, and duration of follow-up) were conducted to explore heterogeneity. Dose-response analyses were performed utilizing three model types.
resultsFollowing the screening of 27,278 articles, 23 articles have been included in this study finally. The associations between TG, TC, HDL, and LDL levels and the risk of CRC, colon, and rectum cancers were examined separately. Higher levels of TC were not significantly associated with the risk of CRC (HR = 1.08; 95% CI: 0.90-1.30; I2 = 50.55%; p = 0.4187) and colon cancer (HR = 1.08; 95% CI: 0.99-1.18; I2 = 35.57%; p = 0.0720), but were significantly associated with an increased risk of rectum cancer (HR = 1.19; 95% CI: 1.08-1.32; I2 = 28.36%; p = 0.0004). Higher levels of TG were associated with an increased hazard of CRC (HR 1.11; 95% CI: 1.044-1.18; I2 = 0.0%; p = 0.0008). For colon cancer, TG showed a marginally significant association (HR 1.23; 95% CI: 0.99-1.55; I2 = 52.0%; p = 0.0576). No significant association was found between TG levels and rectum cancer risk (HR 1.036; 95% CI: 0.69-1.56; I2 = 67.29%; p = 0.8674).Also, higher levels of HDL were not significantly associated with the risk of CRC (HR 0.93; 95% CI: 0.83-1.03; I2 = 28.8%; p = 0.1527), colon cancer (HR 0.94; 95% CI: 0.75-1.19; I2 = 0.0%; p = 0.6243), and rectum cancer (HR: 0.95; 95% CI: 0.66;1.37; I2 = 0.0%; p = 0.7888). For colon cancer, higher LDL level was not significantly associated with risk (HR 0.91; 95% CI: 0.60-1.37; p = 0.21; I2 = 37%; p = 6558). Accordingly quadratic and RCS models represented as lowest AIC for TC (p = 0.026), for TG (p = 0.004), for LDL (p = 0.942) and for HDL (p = 0.295).
conclusionHigher TG level was significantly associated with increased risk of CRC and showed a borderline association with colon cancer (HR 1.23, 95% CI 0.99-1.55; p = 0.0576), while TC, HDL, and LDL showed no significant associations with these cancers. For rectum cancer, higher TC was significantly linked to increased risk, whereas TG, HDL, and LDL showed no significant associations. Future research should prioritize longitudinal studies to investigate the mechanistic roles of hormones and the gut microbiota in modulating colorectal cancer risk, alongside multi-omics studies that integrate lipid metabolism with other biological variables such as inflammatory markers and genetic predispositions. These efforts could clarify causal pathways and inform targeted prevention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.